Early complications in flexible bronchoscopy at a university hospital
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
Autores
Citação
JORNAL BRASILEIRO DE PNEUMOLOGIA, v.46, n.4, article ID e20180125, 6p, 2020
Resumo
Objective: To analyze the complications related to flexible bronchoscopy (FB) and its collection procedures in outpatients and inpatients with various lung and airway diseases treated at a university hospital. Methods: This was a retrospective analysis of complications occurring during or within 2 h after FB performed between January of 2012 and December of 2013, as recorded in the database of the respiratory endoscopy department of a hospital complex in the city of Sao Paulo, Brazil. Results: We analyzed 3,473 FBs. Complications occurred in 185 procedures (5.3%): moderate to severe bleeding, in 2.2%; pneumothorax, in 0.7%; severe bronchospasm, in 0.8%; general complications (hypoxemia, psychomotor agitation, arrhythmias, vomiting, or hypotension), in 1.6%; and cardiopulmonary arrest, in 0.03%. There were no deaths related to the procedures. Specifically, among the 1,728 patients undergoing biopsy, bronchial brushing, or fine-needle aspiration biopsy, bleeding occurred in 75 (4.3%). Among the 1,191 patients undergoing transbronchial biopsy, severe pneumothorax (requiring chest tube drainage) occurred in 24 (2.0%). Conclusions: In our patient sample, FB proved to be a safe method with a low rate of complications. Appropriate continuing training of specialist doctors and nursing staff, as well as the development of standardized care protocols, are important for maintaining those standards.
Palavras-chave
Bronchoscopy/adverse effects, Biopsy/adverse effects, Pneumothorax
Referências
- Alamoudi OS, 2000, SAUDI MED J, V21, P1043
- Alzeer AH, 2008, SAUDI MED J, V29, P55
- Amer Soc Anesthesiologists, 2017, ANESTHESIOLOGY, V126, P376, DOI 10.1097/ALN.0000000000001452
- BLASCO LH, 1991, CHEST, V99, P562, DOI 10.1378/chest.99.3.562
- Carr IM, 2012, RESPIRATION, V84, P312, DOI 10.1159/000339507
- Colt HG, 2001, RESPIRATION, V68, P67, DOI 10.1159/000050465
- de Blic J, 2002, EUR RESPIR J, V20, P1271, DOI 10.1183/09031936.02.02072001
- Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618
- Ernst A, 2006, CHEST, V129, P734, DOI 10.1378/chest.129.3.734
- Facciolongo N, 2009, Monaldi Arch Chest Dis, V71, P8
- FRAZIER WD, 1990, CHEST, V97, P539, DOI 10.1378/chest.97.3.539
- Geraci G, 2007, ANN ITAL CHIR, V78, P183
- Hankey GJ, 2011, CIRCULATION, V123, P1436, DOI 10.1161/CIRCULATIONAHA.110.004424
- Ibrahim AS, 2005, SAUDI MED J, V26, P641
- Jin FG, 2008, RESPIRATION, V76, P429, DOI 10.1159/000151656
- Joos L, 2006, SWISS MED WKLY, V136, P155
- Kaparianos A, 2008, EUR REV MED PHARMACO, V12, P355
- KLECH H, 1989, EUR RESPIR J, V2, P561
- MILMAN N, 1994, RESP MED, V88, P749, DOI 10.1016/S0954-6111(05)80197-0
- PUE CA, 1995, CHEST, V107, P430, DOI 10.1378/chest.107.2.430
- Spyropoulos AC, 2012, BLOOD, V120, P2954, DOI 10.1182/blood-2012-06-415943
- Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000
- Tukey MH, 2012, RESP MED, V106, P1559, DOI 10.1016/j.rmed.2012.08.008
- van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758